Novozymes A/S's ticker is NVZMY and the CUSIP is 670108109. A total of 17 filers reported holding Novozymes A/S in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $93,000 | -40.4% | 1,980 | -48.1% | 0.01% | -54.2% |
| Q3 2019 | $156,000 | -40.7% | 3,813 | -33.7% | 0.02% | -42.9% |
| Q2 2019 | $263,000 | +8.2% | 5,748 | +5.8% | 0.04% | -2.3% |
| Q1 2019 | $243,000 | +57.8% | 5,434 | +52.2% | 0.04% | +4.9% |
| Q4 2018 | $154,000 | +48.1% | 3,571 | +77.6% | 0.04% | +36.7% |
| Q3 2018 | $104,000 | +9.5% | 2,011 | 0.0% | 0.03% | -9.1% |
| Q2 2018 | $95,000 | +55.7% | 2,011 | +60.8% | 0.03% | +50.0% |
| Q1 2018 | $61,000 | +3.4% | 1,251 | +16.3% | 0.02% | -8.3% |
| Q4 2017 | $59,000 | +18.0% | 1,076 | +5.2% | 0.02% | +14.3% |
| Q3 2017 | $50,000 | +16.3% | 1,023 | 0.0% | 0.02% | +10.5% |
| Q2 2017 | $43,000 | +13.2% | 1,023 | 0.0% | 0.02% | +11.8% |
| Q1 2017 | $38,000 | – | 1,023 | +4347.8% | 0.02% | – |
| Q4 2016 | $0 | -100.0% | 23 | -88.8% | 0.00% | -100.0% |
| Q3 2016 | $9,000 | 0.0% | 205 | -12.0% | 0.01% | 0.0% |
| Q2 2016 | $9,000 | 0.0% | 233 | +13.7% | 0.01% | 0.0% |
| Q1 2016 | $9,000 | -50.0% | 205 | -48.0% | 0.01% | -50.0% |
| Q4 2015 | $18,000 | +1700.0% | 394 | +1307.1% | 0.01% | +1100.0% |
| Q2 2015 | $1,000 | – | 28 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ZEVIN ASSET MANAGEMENT LLC | 53,160 | $3,191,000 | 0.72% |
| Boston Common Asset Management, LLC | 18,087 | $1,083,000 | 0.05% |
| ST GERMAIN D J CO INC | 5,000 | $300,000 | 0.02% |
| Private Capital Group, LLC | 395 | $24,000 | 0.02% |
| CAPTRUST FINANCIAL ADVISORS | 3,579 | $215,000 | 0.00% |
| MAR VISTA INVESTMENT PARTNERS LLC | 273 | $16,000 | 0.00% |
| Financial Avengers, Inc. | 10 | $1,000 | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 3,830 | $229,000 | 0.00% |